Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 110

    1.

    Liver transplantation for cholangiocarcinoma.

    Schwartz JJ, Hutson WR, Gayowski TJ, Sorensen JB.

    Transplantation. 2009 Aug 15;88(3):295-8. Review.PMID: 19667927 [PubMed - indexed for MEDLINE]Related articles

    2.

    The hepatoadrenal syndrome: a common yet unrecognized clinical condition.

    Marik PE, Gayowski T, Starzl TE; Hepatic Cortisol Research and Adrenal Pathophysiology Study Group.

    Crit Care Med. 2005 Jun;33(6):1254-9.PMID: 15942340 [PubMed - indexed for MEDLINE]Related articles

    3.

    Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years.

    Singh N, Wannstedt C, Keyes L, Wagener MM, Gayowski T, Cacciarelli TV.

    Transplantation. 2005 May 27;79(10):1428-34.PMID: 15912115 [PubMed - indexed for MEDLINE]Related articles

    4.

    Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease.

    Singh N, Wannstedt C, Keyes L, Gayowski T, Wagener MM, Cacciarelli TV.

    Transplantation. 2005 Jan 15;79(1):85-90.PMID: 15714174 [PubMed - indexed for MEDLINE]Related articles

    5.

    T-helper cell responses in liver transplant recipients: correlation with cytomegalovirus and other major infections.

    Singh N, Gayowski T, Wagener MM, Zeevi A.

    Transpl Infect Dis. 2004 Jun;6(2):93-6.PMID: 15522114 [PubMed - indexed for MEDLINE]Related articles

    6.

    Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.

    Marcos A, Eghtesad B, Fung JJ, Fontes P, Patel K, Devera M, Marsh W, Gayowski T, Demetris AJ, Gray EA, Flynn B, Zeevi A, Murase N, Starzl TE.

    Transplantation. 2004 Oct 15;78(7):966-71.PMID: 15480160 [PubMed - indexed for MEDLINE]Related articles

    7.

    Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens.

    Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T.

    Liver Transpl. 2004 Jul;10(7):844-9.PMID: 15237367 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cryptococcus neoformans Infection in Patients With Cirrhosis, Including Liver Transplant Candidates.

    Singh N, Husain S, De Vera M, Gayowski T, Cacciarelli TV.

    Medicine (Baltimore). 2004 May;83(3):188-92.PMID: 15118545 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients.

    Singh N, Wannstedt C, Keyes L, Wagener MM, de Vera M, Cacciarelli TV, Gayowski T.

    Transplantation. 2004 Jan 15;77(1):106-10.PMID: 14724443 [PubMed - indexed for MEDLINE]Related articles

    10.

    Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit.

    Singh N, Wagener MM, Gayowski T.

    Clin Microbiol Infect. 2003 Jun;9(6):531-7.PMID: 12848729 [PubMed - indexed for MEDLINE]Related articles

    11.

    Tolerogenic immunosuppression for organ transplantation.

    Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T, Bond G, Scantlebury VP, Potdar S, Randhawa P, Wu T, Zeevi A, Nalesnik MA, Woodward J, Marcos A, Trucco M, Demetris AJ, Fung JJ.

    Lancet. 2003 May 3;361(9368):1502-10.PMID: 12737859 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.

    Paterson DL, Rihs JD, Squier C, Gayowski T, Sagnimeni A, Singh N.

    Transplantation. 2003 Jan 27;75(2):194-8.PMID: 12548122 [PubMed - indexed for MEDLINE]Related articles

    13.

    Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.

    Singh N, Wagener MM, Gayowski T.

    Transplantation. 2002 Sep 27;74(6):892-5.PMID: 12364876 [PubMed - indexed for MEDLINE]Related articles

    14.

    Persistent lack of human herpesvirus-6 specific T-helper cell response in liver transplant recipients.

    Singh N, Bentlejewski C, Carrigan DR, Gayowski T, Knox KK, Zeevi A.

    Transpl Infect Dis. 2002 Jun;4(2):59-63.PMID: 12220240 [PubMed - indexed for MEDLINE]Related articles

    15.

    Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes.

    Venkataramanan R, Zang S, Gayowski T, Singh N.

    Antimicrob Agents Chemother. 2002 Sep;46(9):3091-3.PMID: 12183280 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Bleeding complications precipitated by unrecognized Gingko biloba use after liver transplantation.

    Hauser D, Gayowski T, Singh N.

    Transpl Int. 2002 Jul;15(7):377-9. Epub 2002 Jun 19.PMID: 12122516 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.

    Muder RR, Agarwala S, Mirani A, Gayowski T, Venkataramanan R.

    J Clin Pharmacol. 2002 Jun;42(6):644-50.PMID: 12043952 [PubMed - indexed for MEDLINE]Related articles

    18.

    Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients.

    Singh N, Husain S, Carrigan DR, Knox KK, Weck KE, Wagener MM, Gayowski T.

    Clin Transplant. 2002 Apr;16(2):92-6.PMID: 11966777 [PubMed - indexed for MEDLINE]Related articles

    19.

    Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices.

    Singh N, Wagener MM, Marino IR, Gayowski T.

    Transplantation. 2002 Jan 15;73(1):63-7.PMID: 11792979 [PubMed - indexed for MEDLINE]Related articles

    20.

    Seasonal pattern of early mortality and infectious complications in liver transplant recipients.

    Singh N, Wagener MM, Gayowski T.

    Liver Transpl. 2001 Oct;7(10):884-9.PMID: 11679987 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy.

    Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR.

    Transplantation. 2001 Apr 15;71(7):910-3.PMID: 11349726 [PubMed - indexed for MEDLINE]Related articles

    22.

    Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients.

    Singh N, Gayowski T, Wagener MM.

    Liver Transpl. 2001 Feb;7(2):100-5.PMID: 11172392 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns.

    Singh N, Gayowski T, Rihs JD, Wagener MM, Marino IR.

    Liver Transpl. 2001 Jan;7(1):22-6. Erratum in: Liver Transpl 2001 May;7(5):471. PMID: 11150417 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Psychological characteristics of candidates for liver transplantation: differences according to history of substance abuse and UNOS listing. United Network for Organ Sharing.

    Stilley CS, Miller DJ, Gayowski T, Marino IR.

    J Clin Psychol. 1999 Oct;55(10):1287-97.PMID: 11045777 [PubMed - indexed for MEDLINE]Related articles

    26.

    Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.

    Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, Abu-Elmagd K, Marsh W, Madariaga J, Mazariegos G, Geller D, Bonham CA, Gayowski T, Cacciarelli T, Fontes P, Starzl TE, Fung JJ.

    Ann Surg. 2000 Oct;232(4):490-500.PMID: 10998647 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome.

    Rogers J, Rohal S, Carrigan DR, Kusne S, Knox KK, Gayowski T, Wagener MM, Fung JJ, Singh N.

    Transplantation. 2000 Jun 27;69(12):2566-73.PMID: 10910278 [PubMed - indexed for MEDLINE]Related articles

    28.

    Late-onset renal failure after liver transplantation: role of posttransplant alcohol use.

    Gayowski T, Singh N, Keyes L, Wannstedt CF, Wagener MM, Vargas H, Laskus T, Rakela J, Fung JJ, Marino IR.

    Transplantation. 2000 Feb 15;69(3):383-8.PMID: 10706047 [PubMed - indexed for MEDLINE]Related articles

    29.

    Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis.

    Paterson DL, Gayowski T, Wannstedt CF, Wagener MM, Marino IR, Vargas H, Laskus T, Rakela J, Singh N.

    Clin Transplant. 2000 Feb;14(1):48-54.PMID: 10693635 [PubMed - indexed for MEDLINE]Related articles

    30.

    Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients.

    Singh N, Paterson DL, Chang FY, Gayowski T, Squier C, Wagener MM, Marino IR.

    Clin Infect Dis. 2000 Feb;30(2):322-7.PMID: 10671336 [PubMed - indexed for MEDLINE]Related articles

    31.

    Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin.

    Chang FY, Singh N, Gayowski T, Wagener MM, Mietzner SM, Stout JE, Marino IR.

    Transplantation. 2000 Jan 15;69(1):70-5.PMID: 10653383 [PubMed - indexed for MEDLINE]Related articles

    32.

    Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D.

    Taniguchi M, Shakil AO, Vargas HE, Laskus T, Demetris AJ, Gayowski T, Dodson SF, Fung JJ, Rakela J.

    Liver Transpl. 2000 Jan;6(1):92-6.PMID: 10648584 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Predicting bacteremia and bacteremic mortality in liver transplant recipients.

    Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR.

    Liver Transpl. 2000 Jan;6(1):54-61.PMID: 10648578 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Fever in liver transplant recipients in the intensive care unit.

    Singh N, Chang FY, Gayowski T, Wagener M, Marino IR.

    Clin Transplant. 1999 Dec;13(6):504-11.PMID: 10617241 [PubMed - indexed for MEDLINE]Related articles

    35.

    Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient.

    Paterson DL, Singh N, Gayowski T, Carrigan DR, Marino IR.

    Liver Transpl Surg. 1999 Sep;5(5):454-5.PMID: 10477848 [PubMed - indexed for MEDLINE]Related articles

    36.

    Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system.

    Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, Geller DA, Gayowski TJ, Fung JJ, Starzl TE.

    J Am Coll Surg. 1999 Sep;189(3):291-9.PMID: 10472930 [PubMed - indexed for MEDLINE]Related articles

    37.

    Intraoperative hypothermia is an independent risk factor for early cytomegalovirus infection in liver transplant recipients.

    Paterson DL, Staplefeldt WH, Wagener MM, Gayowski T, Marino IR, Singh N.

    Transplantation. 1999 Apr 27;67(8):1151-5.PMID: 10232566 [PubMed - indexed for MEDLINE]Related articles

    38.

    Pulmonary infiltrates in liver transplant recipients in the intensive care unit.

    Singh N, Gayowski T, Wagener MM, Marino IR.

    Transplantation. 1999 Apr 27;67(8):1138-44.PMID: 10232564 [PubMed - indexed for MEDLINE]Related articles

    39.

    Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.

    Paterson DL, Singh N, Gayowski T, Marino IR.

    Clin Infect Dis. 1999 Mar;28(3):683-4. No abstract available. PMID: 10194100 [PubMed - indexed for MEDLINE]Related articles

    40.

    Quality of life and functional status of liver transplant recipients with recurrent viral hepatitis C.

    Gayowski T, Wagener MM, Marino IR, Singh N.

    Transplant Proc. 1999 Feb-Mar;31(1-2):1386-7. No abstract available. PMID: 10083613 [PubMed - indexed for MEDLINE]Related articles

    41.

    Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C.

    Singh N, Gayowski T, Wagener MM, Marino IR.

    Transplantation. 1999 Jan 15;67(1):69-72.PMID: 9921798 [PubMed - indexed for MEDLINE]Related articles

    42.

    Mycobacterium mucogenicum bacteremia in a patient with cirrhosis.

    Paterson DL, Singh N, Gayowski T, Marino IR.

    J Clin Gastroenterol. 1998 Dec;27(4):346-7. No abstract available. PMID: 9855267 [PubMed - indexed for MEDLINE]Related articles

    43.

    Psychological characteristics of candidates for liver transplantation.

    Stilley CS, Miller DJ, Gayowski T, Marino IR.

    Clin Transplant. 1998 Oct;12(5):416-24.PMID: 9787951 [PubMed - indexed for MEDLINE]Related articles

    44.

    Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil.

    Paterson DL, Singh N, Panebianco A, Wannstedt CF, Wagener MM, Gayowski T, Marino IR.

    Transplantation. 1998 Sep 15;66(5):593-8.PMID: 9753337 [PubMed - indexed for MEDLINE]Related articles

    45.

    Matching donors and recipients.

    Marino IR, Doria C, Doyle HR, Gayowski TJ.

    Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S115-9.PMID: 9742504 [PubMed - indexed for MEDLINE]Related articles

    46.

    Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis.

    Singh N, Zeevi A, Gayowski T, Marino IR.

    Transpl Int. 1998;11(4):308-11.PMID: 9704398 [PubMed - indexed for MEDLINE]Related articles

    47.

    Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection.

    Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR.

    Infect Control Hosp Epidemiol. 1998 May;19(5):328-32.PMID: 9613693 [PubMed - indexed for MEDLINE]Related articles

    48.

    Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients.

    Chang FY, Singh N, Gayowski T, Drenning SD, Wagener MM, Marino IR.

    Transplantation. 1998 May 15;65(9):1169-72.PMID: 9603162 [PubMed - indexed for MEDLINE]Related articles

    49.

    Mitochondrial redox state as a potential detector of liver dysoxia in vivo.

    Dishart MK, Schlichtig R, Tonnessen TI, Rozenfeld RA, Simplaceanu E, Williams D, Gayowski TJ.

    J Appl Physiol. 1998 Mar;84(3):791-7.PMID: 9480934 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen.

    Singh N, Gayowski T, Marino IR.

    Transpl Int. 1998;11(1):63-5.PMID: 9503557 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...